Watts Ryan J. 4
4 · Denali Therapeutics Inc. · Filed Mar 29, 2024
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Gift
Common Stock
2024-03-29−40,000→ 2,202,604 total(indirect: See footnote)
Holdings
- 238,067
Common Stock
Footnotes (3)
- [F1]Reflects an in-kind charitable contribution of 40,000 shares of DNLI to a donor advised fund.
- [F2]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
- [F3]Includes 202,200 unvested RSUs.